CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Roth Capital Initiates Coverage on Coya Therapeutics With Buy Rating, $12 Price Target

Positive
AI Analysis

Summary

Roth Capital initiated coverage on Coya Therapeutics with a Buy rating and $12 price target. This represents routine analyst research initiation with no material clinical, regulatory, or financial developments.

Importance:3/10
Sentiment:
0.60
analyst_coverageprice_targetbuy_rating
Related Companies

Read the original article

Published by yahoo_finance on June 5, 2026 11:28 AM

Read Original